Finzati - Logo
MYGN logo

Myriad Genetics, Inc.

MYGN • Medical - Diagnostics & Research
$4.21
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$394.48M
Growth
13.1%
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.57Healthy liquidity · 2.49Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 5, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$4.21
Change0.00%
Shares Out93.70M
Market Cap$394.48M
Enterprise Value$481.58M
52W Range3.53 - 8.59
Beta1.92
P/E-0.99
P/S0.48
P/B1.17
P/FCF-23.62
EV/Sales0.58

Investment DNA

How strong this company looks for long-term investors

41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
73/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
93/100
Why this score▼
Manageable debt level · 0.57Healthy liquidity · 2.49Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

MYGN
Analyst sentiment
Based on 37 analyst votes · 2026-10-20
51/100
Neutral
Bullish
8
Hold
22
Bearish
7
Price Target
2026-06-24
Low
$6.00
Mean
$6.00
Median
$6.00
High
$6.00

Company Overview

IPO: 10/6/1995
Industry: Medical - Diagnostics & Research
P/B i: 1.17
Debt / Equity i: 0.57
Operating Margin: -8.22%
Net Margin: -44.38%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.57
Current Ratio: 2.49
Quick Ratio: 2.26
Status: Good

Insider Transactions

Recent executive and insider activity

Skovronsky Daniel
Transaction: 06/23/2026
OTHER
Change
0
Price
Not reported
Filing
06/23/2026
Type
OTHER
Donnelly Brian J
Transaction: 06/11/2026
BUY
Change
+5,000
Price
$3.94
Filing
06/12/2026
Type
BUY
Raha Samraat S.
Transaction: 06/11/2026
BUY
Change
+3,542
Price
$3.94
Filing
06/12/2026
Type
BUY